| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Workplace Communication > How To Beat Office Politics |
|
Useful Advices - How To Beat Office Politics
As I am no longer involved in Corporate Office affairs I am conscious in writing this article I am in danger of s According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ounding like a grumpy old man. But in relation to corporate office politics I saw something this week that astoun ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ded me. In The Times of London on a management and business page there was a write up with photograph of a chap lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. who coaches people in how to succeed at office politics. I only glanced at the article but it stayed with me. As here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe someone who has run major corporate businesses and eventually went on to found my own businesses it caused me to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro reflect. My style of management was to be open to avoid confusion and office politics by keeping everyone in the ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc business informed on what we were attempting to achieve. It was their lively hood after all. We worked hard at easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi a structured briefing method, departmental groups were informed by the head of department what the latest issues nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically were. The heads of department had been briefed by me and it was mandatory that any questions were answered there and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ and then. If an answer was not possible the question had to be fed back to me and I would give the answer. The me ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi etings were monthly. This method of communication worked brilliantly, as we were able to bring about major chang ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e and re-organisation including job losses without any repercussions that threatened the business. There could be dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod no corporate office politics because every one was fully briefed and all knew what the situation was. The artic cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin le about coaching people how to succeed at corporate office politics is the opposite of what is needed. To succee tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen d we all need to work together with common goals. This applies in any business and honest open communication is a t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel n essential in this process. However, I also have another take on it. The chap who has developed the course is o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust bviously selling to the large corporates and getting coverage in one of the top newspapers. Which shows that ther y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e is a market. So best of luck to him for having the initiative to spot the opportunity. Which leads me to anoth . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de er point that you have heard me go on about before. When you have your own business you see opportunity every whe elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip re. Just another reason for escaping the office politics and exploiting the opportunities which are there for us. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Overcoming Inertia in Job Change The Truth Is, Your Optimal Leverage Is Your Key To Home Business Success Networking For Your Employer is Great For Building Your Personal Rolodex
|